Skip to content

Welcome to Discover Pharma! Today is : November 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital & Data

  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data

    Qureight names Rebecca Simmons COO to lead operational scaling

    Qureight has appointed Rebecca Simmons as chief operating officer, strengthening [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Gap emerges between agentic AI ambition and real-world use in pharma, report finds

    A growing gap has emerged between how life sciences and [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data

    Qureight appoints Steven Bishop as Chief Medical Officer

    Qureight has appointed Steven Bishop as chief medical officer, marking [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    PharmaForceIQ acquires Aktana to expand AI-driven pharma engagement platform

    PharmaForceIQ has acquired Aktana, bringing together a digital commercial orchestration [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    FluoSphera raises €1.23 million to scale human-based preclinical testing platform

    Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Breast cancer tops list of most-studied diseases for fifth consecutive year, Phesi analysis finds

    Breast cancer remained the world’s most studied disease for the [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Trialbee secures majority investment from Varsity Healthcare Partners to scale patient recruitment

    Trialbee has secured a majority growth investment from Varsity Healthcare [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    May 5, 2026
Previous151617Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Passive cough monitoring linked to worsening asthma symptoms
    Categories: Digital & Data, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • NIH funds expanded access programme for Neurizon’s ALS therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Sapience Therapeutics gets FDA clearance for ST316 FAP study
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top